PDCD1 and cancer: The remarkable immunosuppressive effect of MDSC in tumors blocks the immunotherapeutic effect of target programmed cell death protein 1 (PD-1), but the cruciferous product 3,3 ‘-diindolylmethane (DIM) can promote T cell responses to enhance the therapeutic effect of PD-1 antibodies, thus arresting cancer cell proliferation (146).